NCT03190174 2025-02-17Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain CancersSarcoma Oncology Research Center, LLCPhase 1/2 Completed34 enrolled 14 charts
NCT00287846 2016-08-30Imatinib Mesylate in Treating Patients With Recurrent or Refractory FibromatosisUNICANCERPhase 1/2 Completed40 enrolled